Works matching IS 13479032 AND DT 2014 AND VI 105 AND IP 10


Results: 21
    1

    Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models.

    Published in:
    Cancer Science, 2014, v. 105, n. 10, p. 1334, doi. 10.1111/cas.12488
    By:
    • Funahashi, Yasuhiro;
    • Okamoto, Kiyoshi;
    • Adachi, Yusuke;
    • Semba, Taro;
    • Uesugi, Mai;
    • Ozawa, Yoichi;
    • Tohyama, Osamu;
    • Uehara, Taisuke;
    • Kimura, Takayuki;
    • Watanabe, Hideki;
    • Asano, Makoto;
    • Kawano, Satoshi;
    • Tizon, Xavier;
    • McCracken, Paul J.;
    • Matsui, Junji;
    • Aoshima, Ken;
    • Nomoto, Kenichi;
    • Oda, Yoshiya
    Publication type:
    Article
    2
    3

    In vivo tumor imaging using fluorescence conjugated anti-CEA antibody by two-photon excitation microscopy. A three-dimensional image of site inoculated with MKN-GFP gastric carcinoma cells preincubated with fluorescence conjugated anti-CEA antibody was obtained by two-photon excitation microscopy

    Published in:
    2014
    By:
    • Koga, Shigehiro;
    • Oshima, Yusuke;
    • Honkura, Naoki;
    • Iimura, Tadahiro;
    • Kameda, Kenji;
    • Sato, Koichi;
    • Yoshida, Motohira;
    • Yamamoto, Yuji;
    • Watanabe, Yuji;
    • Hikita, Atsuhiko;
    • Imamura, Takeshi
    Publication type:
    Other
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Issue Information.

    Published in:
    Cancer Science, 2014, v. 105, n. 10, p. i, doi. 10.1111/cas.12263
    Publication type:
    Article
    16
    17
    18
    19
    20
    21